NIH unit awards $36M grant to Beth Israel for AIDS vaccine research

07/25/2011 | American City Business Journals

The NIH's National Institute of Allergy and Infectious Diseases has awarded a $36 million grant to Beth Israel Deaconess Medical Center to spearhead a consortium that aims to study AIDS vaccines in nonhuman primates. The grant will be distributed over five years. "The goal of the consortium is to elucidate the earliest immunologic and pathologic events at mucosal surfaces following virus infection, and to determine the ability of multiple leading vaccine candidates to block or to attenuate these events," said Dr. Dan Barouch, chief of vaccine research at Beth Israel.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN